Neal Kleiman Professor of Medicine
Professor of Medicine, Medicine , Weill Cornell Medical College 2006 -
Association between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. JAMA - Journal of the American Medical Association. 2019 Academic Article GET IT
Surgical bailout for left ventricular outflow tract obstruction following a complicated mitral valve-in-valve procedure. Cardiovascular Revascularization Medicine. 2019 Academic Article GET IT
Too Thick to Cut With SISRs. Circulation: Cardiovascular Interventions. 2018 Editorial Article GET IT
Delayed Coronary Obstruction After TAVR: A Call for Vigilance∗. Journal of the American College of Cardiology. 2018 Article GET IT
Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve. Journal of Invasive Cardiology. 2018 Academic Article GET IT
Bleeding Edge Technology: Retroperitoneal Hemorrhage and Its Implications for Transradial Access. Circulation: Cardiovascular Interventions. 2018 Editorial Article GET IT
Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk of Stroke After Coronary Stenting. JACC: Cardiovascular Interventions. 2018 Editorial Article GET IT
Trends and outcomes of off-label use of transcatheter aortic valve replacement: Insights from the NCDR STS/ACC TVT registry. JAMA Cardiology. 2017 Academic Article GET IT
Association between hospital volume and 30-day readmissions following transcatheter aortic valve replacement. JAMA Cardiology. 2017 Academic Article GET IT
At Arm's Length: Radiation Safety During Radial Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 2017 Editorial Article GET IT
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC: Cardiovascular Interventions. 2017 Academic Article GET IT
One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. Annals of Thoracic Surgery. 2017 Academic Article GET IT
Bioresorbable scaffold: The emerging reality and future directions. Circulation Research. 2017 Review GET IT
Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. New England Journal of Medicine. 2017 Academic Article GET IT
Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Cardiovascular Revascularization Medicine. 2017 Academic Article GET IT
New-Generation Coronary Stents: Current Data and Future Directions. Current atherosclerosis reports. 2017 Review GET IT
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. Journal of the American College of Cardiology. 2017 Academic Article GET IT
A 24-Month Interventional Cardiology Fellowship: Learning Motor Skills Through Blocked Repetition. JACC: Cardiovascular Interventions. 2017 Article GET IT
Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center. Journal of Thoracic and Cardiovascular Surgery. 2017 Academic Article GET IT
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 2017 Academic Article GET IT
Optimizing Management of Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: The Importance of Distinguishing Pre-Existing From New Onset Atrial Fibrillation. JACC: Cardiovascular Interventions. 2017 Article GET IT
Structural Heart Interventional Training: The Next Steps. JACC: Cardiovascular Interventions. 2016 Article GET IT
Highway to the heart or one more for the road? The continued life of direct aortic access for transcatheter aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery. 2016 Editorial Article GET IT
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report from the CoreValve Trials. Circulation: Cardiovascular Interventions. 2016 Academic Article GET IT
The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients∗. JACC: Cardiovascular Interventions. 2016 Editorial Article GET IT
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). American Journal of Cardiology. 2016 Academic Article GET IT
Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance. Journal of the American College of Cardiology. 2016 Editorial Article GET IT
Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. Journal of Thrombosis and Thrombolysis. 2016 Academic Article GET IT
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery. 2016 Academic Article GET IT
Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Catheterization and Cardiovascular Interventions. 2016 Academic Article GET IT
VWF, ADAMTS13, and acute coronary syndromes. Blood. 2016 Academic Article GET IT
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology. 2016 Academic Article GET IT
Early recovery of left ventricular systolic function after corevalve transcatheter aortic valve replacement. Circulation: Cardiovascular Interventions. 2016 Academic Article GET IT
Causes of death from the randomized CoreValve US Pivotal High-Risk Trial. Journal of Thoracic and Cardiovascular Surgery. 2016 Academic Article GET IT
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. Journal of Thoracic and Cardiovascular Surgery. 2016 Academic Article GET IT
How Many Roads Lead to Rome?. JACC: Cardiovascular Interventions. 2016 Article GET IT
What happens in the cath lab stays in the cath lab, or does it? Intraprocedural thrombotic events in patients with acute coronary syndromes. JACC: Cardiovascular Interventions. 2016 Article GET IT
Minimally invasive repair of left ventricular pseudoaneurysm after transapical transcatheter aortic valve replacement. Texas Heart Institute Journal. 2016 Academic Article GET IT
Watching a Procedure Evolve: Sequential Findings From the TVT Registry. Annals of Thoracic Surgery. 2016 Editorial Article GET IT
Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists. Catheterization and Cardiovascular Interventions. 2016 Editorial Article GET IT
Von Willebrand factor, paravalvular leak, and a new vista for TAVR. Journal of Thoracic Disease. 2016 Article GET IT
Watching a Procedure Evolve Sequential Findings from the TVT Registry. Journal of the American College of Cardiology. 2015 Editorial Article GET IT
At 5 years, transcatheter aortic valve replacement had similar rates of mortality and stroke as surgical aortic valve replacement in high-risk patients. Evidence-Based Medicine. 2015 Article GET IT
Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation from the CoreValve U.S. Pivotal Trial. JACC: Cardiovascular Imaging. 2015 Academic Article GET IT
Transcatheter treatment of apicoaortic conduit dysfunction. Journal of Cardiac Surgery. 2015 Academic Article GET IT
2-Year Outcomes after Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed Extreme Risk for Surgery. Journal of the American College of Cardiology. 2015 Academic Article GET IT
Direct Aortic Access Transcatheter Aortic Valve Replacement: Three-Dimensional Computed Tomography Planning and Real-Time Fluoroscopic Image Guidance. The Journal of heart valve disease. 2015 Academic Article GET IT
Short-Term Outcomes with Direct Aortic Access for Transcatheter Aortic Valve Replacement. The Journal of heart valve disease. 2015 Academic Article GET IT
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology. 2015 Academic Article GET IT
Bioprosthetic mitral transcatheter transapical valve-in-valve implantation for mitral stenosis in an end-stage renal disease patient. Journal of Cardiac Surgery. 2015 Academic Article GET IT
Expanding the roster: Developing new inhibitors of intravascular thrombosis. Journal of the American College of Cardiology. 2015 Editorial Article GET IT
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: Results from the CoreValve U.S. Trial. JACC: Cardiovascular Interventions. 2015 Academic Article GET IT
Is it time to join the cult? Radial access and percutaneous coronary intervention. Circulation: Cardiovascular Interventions. 2015 Article GET IT
Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trial. International Journal of Endocrinology. 2015 Academic Article GET IT
Suicide left ventricle due to conduction disturbance following transcatheter aortic valve replacement and reversal with restoration of sinus rhythm: Is there life after death?. Journal of Invasive Cardiology. 2015 Academic Article GET IT
Transesophageal echocardiography-guided percutaneous intervention for a mitral valve leaflet perforation. JACC: Cardiovascular Interventions. 2015 Article GET IT
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the multicenter protect II randomized study). American Journal of Cardiology. 2014 Academic Article GET IT
Case report: It wasn't cupid: multimodality imaging of inferior vena cava filter fracture with strut migration to the interventricular septum. Methodist DeBakey cardiovascular journal. 2014 Academic Article GET IT
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: Insights from the PROTECT ΙΙ study. Catheterization and Cardiovascular Interventions. 2014 Academic Article GET IT
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. Journal of the American College of Cardiology. 2014 Academic Article GET IT
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury. American Journal of Physiology - Heart and Circulatory Physiology. 2014 Academic Article GET IT
Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the evaluation of drug eluting stents and ischemic events registry). American Journal of Cardiology. 2014 Academic Article GET IT
Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. Journal of Interventional Cardiology. 2014 Editorial Article GET IT
Association of immature platelets with adverse cardiovascular outcomes. Journal of the American College of Cardiology. 2014 Academic Article GET IT
Direct aortic and subclavian access for transcatheter aortic valve replacement: Decision making and technique. Journal of Thoracic and Cardiovascular Surgery. 2014 Academic Article GET IT
Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: Results from the evaluation of drug-eluting stents and ischemic events registry. Circulation: Cardiovascular Interventions. 2014 Academic Article GET IT
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI randomized controlled trial. European Heart Journal. 2014 Academic Article GET IT
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. Journal of Thoracic and Cardiovascular Surgery. 2014 Academic Article GET IT
Transcatheter aortic-valve replacement with a self-expanding prosthesis. New England Journal of Medicine. 2014 Academic Article GET IT
Times cited: 1403
Prognostic implications of procedural vs spontaneous myocardial infarction: Results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. American Heart Journal. 2013 Academic Article GET IT
Stenting of a left main coronary artery compressed by a dilated main pulmonary artery. Catheterization and Cardiovascular Interventions. 2013 Review GET IT
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. International Journal of Cardiology. 2013 Academic Article GET IT
In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: A report from the evaluation of drug-eluting stents and ischemic events registry. Catheterization and Cardiovascular Interventions. 2013 Academic Article GET IT
Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC: Heart Failure. 2013 Academic Article GET IT
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thrombosis and Haemostasis. 2013 Academic Article GET IT
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years. American Journal of Cardiology. 2013 Review GET IT
Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. American Journal of Cardiology. 2013 Review GET IT
Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC: Cardiovascular Interventions. 2013 Academic Article GET IT
Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. American Heart Journal. 2013 Academic Article GET IT
Stable angina. 2013 Chapter GET IT
Unstable angina and non-ST segment elevation myocardial infarction (acute coronary syndromes). 2013 Chapter GET IT
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era - An aggregate data meta-analysis of 11,148 patients. Circulation Journal. 2013 Academic Article GET IT
Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis. 2013 Academic Article GET IT
In-Hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: A report from the EVENT registry. Catheterization and Cardiovascular Interventions. 2012 Academic Article GET IT
Repeat revascularization after contemporary percutaneous coronary intervention: An evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circulation: Cardiovascular Interventions. 2012 Academic Article GET IT
Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry. Catheterization and Cardiovascular Interventions. 2012 Academic Article GET IT
A prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study. Circulation. 2012 Academic Article GET IT
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). American Journal of Cardiology. 2012 Academic Article GET IT
Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. Journal of Thrombosis and Thrombolysis. 2012 Academic Article GET IT
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: A comprehensive meta-analysisof all randomized clinical trials. Clinical Cardiology. 2012 Review GET IT
Grabbing the horns of a dilemma: The duration of dual antiplatelet therapy after stent implantation. Circulation. 2012 Editorial Article GET IT
Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. International Journal of Cardiology. 2012 Information Resource GET IT
Introduction to transcatheter aortic valve implantation. Methodist DeBakey cardiovascular journal. 2012 Academic Article GET IT
Room considerations with TAVR. Methodist DeBakey cardiovascular journal. 2012 Academic Article GET IT
Troponin criteria for myocardial infarction after percutaneous coronary intervention. Archives of Internal Medicine. 2012 Academic Article GET IT
Interventional approaches to acute coronary syndromes. 2012 Chapter GET IT
Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. Journal of Thrombosis and Thrombolysis. 2012 Academic Article GET IT
Stent-assisted coil embolization of a large fusiform aneurysm of proximal anterior descending artery novel treatment for coronary aneurysms. Circulation: Cardiovascular Interventions. 2012 Academic Article GET IT
Determinants of plasma vitamin D levels in patients with acute coronary syndromes. European Journal of Clinical Investigation. 2011 Academic Article GET IT
ED to catheterization laboratory: A roundtable integrating trials with practice. American Journal of Emergency Medicine. 2011 Review GET IT
Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry. American Heart Journal. 2011 Academic Article GET IT
Survival benefit with drug-eluting stents in observational studies: Fact or artifact?. Circulation: Cardiovascular Quality and Outcomes. 2011 Academic Article GET IT
Balancing hemostasis and thrombosis in interventional vascular medicine and surgery. Methodist DeBakey cardiovascular journal. 2011 Review GET IT
Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: Results from a propensity score-matched analysis of the evaluation of drug-eluting stents and ischemic events (EVENT) registry. Circulation: Cardiovascular Interventions. 2011 Academic Article GET IT
Prognostic implications of creatine kinase-mb elevation after percutaneous coronary intervention: Results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry. Circulation: Cardiovascular Interventions. 2011 Academic Article GET IT
Bringing it all together: Integration of physiology with anatomy during cardiac catheterization. Journal of the American College of Cardiology. 2011 Editorial Article GET IT
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: Insights from temporal analysis of the multicenter evaluation of drug eluting stents and ischemic events (EVENT) Registry. Circulation. 2011 Academic Article GET IT
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "assessment of Pexelizumab in Acute Myocardial Infarction". American Heart Journal. 2011 Academic Article GET IT
Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). American Journal of Cardiology. 2011 Academic Article GET IT
Acute coronary syndromes: From the emergency department to the catheterization laboratory - Integrating evidence from recent ACS/NSTEMI trials into clinical practice: An evidence-based review of recent clinical trial results and report on a roundtable discussion. Journal of Interventional Cardiology. 2011 Review GET IT
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Contemporary Clinical Trials. 2011 Academic Article GET IT
The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circulation: Cardiovascular Quality and Outcomes. 2011 Academic Article GET IT
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis. 2011 Academic Article GET IT
Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: Results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. American Heart Journal. 2011 Academic Article GET IT
TAVI: transcatheter aortic valve implantation. Methodist DeBakey cardiovascular journal. 2011 Academic Article GET IT
The safety of clopidogrel. Expert Opinion on Drug Safety. 2011 Review GET IT
Diagnosis and Treatment of Complications of Coronary and Valvular Interventions. 2010 Chapter GET IT
Future imaging and guidance for endovascular procedures. 2010 Chapter GET IT
Platelet activation patterns in platelet size sub-populations: Differential responses to aspirin in vitro. Journal of Thrombosis and Thrombolysis. 2010 Academic Article GET IT
Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era. American Heart Journal. 2010 Academic Article GET IT
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement: Results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC: Cardiovascular Interventions. 2010 Academic Article GET IT
Predicting restenosis of drug-eluting stents placed in real-world clinical practice derivation and validation of a risk model from the EVENT registry. Circulation: Cardiovascular Interventions. 2010 Academic Article GET IT
PLATO study of ticagrelor versus clopidogrel in patients with high-risk acute coronary syndromes. Current Cardiology Reports. 2010 Article GET IT
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial. Catheterization and Cardiovascular Interventions. 2010 Academic Article GET IT
Resistance or resistors? Has Ohm's law come to antiplatelet therapy?. American Heart Journal. 2010 Editorial Article GET IT
Evaluation of a new heparin agent in percutaneous coronary intervention: Results of the Phase 2 evaluation of M118 in pErcutaNeous coronary intervention (EMINENCE) trial. Circulation. 2010 Academic Article GET IT
Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation. Journal of the American College of Cardiology. 2010 Academic Article GET IT
Mechanical Complications After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction (from APEX-AMI). American Journal of Cardiology. 2010 Academic Article GET IT
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. Journal of Thrombosis and Thrombolysis. 2010 Academic Article GET IT
Intravenous platelet blockade with cangrelor during PCI. New England Journal of Medicine. 2009 Academic Article GET IT
Platelet inhibition with cangrelor in patients undergoing PCI. New England Journal of Medicine. 2009 Academic Article GET IT
Impact of computerized dosing on eptifibatide-associated bleeding and mortality. American Heart Journal. 2009 Academic Article GET IT
Surgical considerations on the use of the percutaneous ventricular assist device TandemHeart® in critical aortic valve stenosis. Thoracic and Cardiovascular Surgeon. 2009 Academic Article GET IT
Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients. Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC: Cardiovascular Interventions. 2009 Academic Article GET IT
CT metrics of airway disease and emphysema in severe COPD. Chest. 2009 Academic Article GET IT
In-Hospital and 1-Year Outcomes Among Unselected Percutaneous Coronary Intervention Patients Treated With Either Sirolimus- or Paclitaxel-Eluting Stents. Results From the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) Registry. JACC: Cardiovascular Interventions. 2009 Academic Article GET IT
Assessment, Mechanisms, and Clinical Implication of Variability in Platelet Response to Aspirin and Clopidogrel Therapy. American Journal of Cardiology. 2009 Review GET IT
Combining Antiplatelet and Anticoagulant Therapies. Journal of the American College of Cardiology. 2009 Review GET IT
Multivessel drug-eluting stenting and impact of diabetes mellitus - A report from the EVENT registry. Catheterization and Cardiovascular Interventions. 2009 Academic Article GET IT
Prior polyvascular disease: Risk factor for adverse ischaemic outcomes in acute coronary syndromes. European Heart Journal. 2009 Academic Article GET IT
Percutaneous Paravalvular Repair. Guidance Using Live 3-Dimensional Transesophageal Echocardiography. Journal of the American College of Cardiology. 2009 Academic Article GET IT
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. American Heart Journal. 2009 Academic Article GET IT
In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents. A Report From the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) Registry. JACC: Cardiovascular Interventions. 2009 Academic Article GET IT
Searching for the Ceiling. New Reflections on the Disposition and Metabolism of Clopidogrel. JACC: Cardiovascular Interventions. 2008 Article GET IT
Clopidogrel and Calcium-Channel Antagonists. Another Drug-Drug Interaction for the Ever-Wary Clinician?. Journal of the American College of Cardiology. 2008 Editorial Article GET IT
Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. American Heart Journal. 2008 Academic Article GET IT
Three-dimensional transesophageal echocardiogram provides real-time guidance during percutaneous paravalvular mitral repair. Circulation: Heart Failure. 2008 Academic Article GET IT
Vascular changes and black hole phenomenon after coronary brachytherapy: A pathologically distinct entity. Journal of Invasive Cardiology. 2008 Review GET IT
Role of Reticulated Platelets and Platelet Size Heterogeneity on Platelet Activity After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology. 2008 Academic Article GET IT
Prevalence and prognostic significance of preprocedural cardiac troponin elevation among pPatients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008 Academic Article GET IT
The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheterization and Cardiovascular Interventions. 2008 Academic Article GET IT
Increased platelet sensitivity among individuals with aspirin resistance - Platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thrombosis and Haemostasis. 2008 Academic Article GET IT
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008 Academic Article GET IT
Platelets: Developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. Platelets. 2008 Review GET IT
Will Measuring Vasodilator-Stimulated Phosphoprotein Phosphorylation Help Us Optimize the Loading Dose of Clopidogrel?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2008 Editorial Article GET IT
Prediction of one-year survival in high-risk patients with acute coronary syndromes: Results from the SYNERGY trial. Journal of General Internal Medicine. 2008 Academic Article GET IT
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Academic Article GET IT
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Archives of Internal Medicine. 2008 Academic Article GET IT
Time to coronary angiography and outcomes among patients with high-risk non-ST-segment-elevation acute coronary syndromes: Results from the SYNERGY trial. Circulation. 2007 Academic Article GET IT
Beyond pharmacology in heart attacks: Coronary stents and stem cells. Heart and Metabolism. 2007 Report
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. American Heart Journal. 2007 Academic Article GET IT
Initial experience with alcohol septal ablation using a novel magnetic navigation system. Journal of Interventional Cardiology. 2007 Academic Article GET IT
Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. Journal of Thrombosis and Thrombolysis. 2007 Academic Article GET IT
Platelet reactivity among Asian Indians and Caucasians. Platelets. 2007 Academic Article GET IT
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA - Journal of the American Medical Association. 2007 Academic Article GET IT
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: A phase II dose-ranging study. European Heart Journal. 2007 Academic Article GET IT
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. American Heart Journal. 2007 Academic Article GET IT
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. Journal of Thrombosis and Haemostasis. 2007 Academic Article GET IT
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheterization and Cardiovascular Interventions. 2007 Academic Article GET IT
Effect of Ranitidine on the Antiplatelet Effects of Aspirin in Healthy Human Subjects. American Journal of Cardiology. 2007 Academic Article GET IT
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel. Thrombosis Research. 2007 Academic Article GET IT
Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. American Heart Journal. 2007 Academic Article GET IT
Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures. Catheterization and Cardiovascular Interventions. 2007 Review GET IT
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. American Heart Journal. 2006 Academic Article GET IT
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Circulation. 2006 Academic Article GET IT
Measuring Troponin Elevation After Percutaneous Coronary Intervention. Ready for Prime Time?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2006 Editorial Article GET IT
Temporal Trends in the Use of Early Cardiac Catheterization in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (Results from CRUSADE). American Journal of Cardiology. 2006 Academic Article GET IT
Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thrombosis and Haemostasis. 2006 Academic Article GET IT
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. American Heart Journal. 2006 Academic Article GET IT
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. American Heart Journal. 2006 Academic Article GET IT
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. American Heart Journal. 2006 Academic Article GET IT
Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy). American Journal of Cardiology. 2006 Academic Article GET IT
Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coronary Artery Disease. 2006 Academic Article GET IT
Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients. An ex vivo human study. Thrombosis and Haemostasis. 2006 Academic Article GET IT
Percutaneous myocardial laser revascularisation may not be effective in severe angina: Commentary. Evidence-based Cardiovascular Medicine. 2006 Article GET IT
Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions. Journal of the American College of Cardiology. 2006 Academic Article GET IT
Therapeutic strategies for cardiogenic shock, 2006. Current Treatment Options in Cardiovascular Medicine. 2006 Article GET IT
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance. Journal of the American College of Cardiology. 2006 Academic Article GET IT
Is aspirin resistance valid?. Future Cardiology. 2006 Editorial Article GET IT
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: Outcomes at 6 months and 1 year in the SYNERGY trial. JAMA - Journal of the American Medical Association. 2005 Academic Article GET IT
Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. American Heart Journal. 2005 Academic Article GET IT
Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. Journal of Vascular Research. 2005 Academic Article GET IT
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes. Heart. 2005 Editorial Article GET IT
Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide?. Nature Clinical Practice Cardiovascular Medicine. 2005 Academic Article GET IT
Resistance to antiplatelet therapy. Current Cardiology Reports. 2005 Review GET IT
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: An analysis from the Randomized Evaluation In Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Journal of the American College of Cardiology. 2005 Academic Article GET IT
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. American Journal of Cardiology. 2005 Academic Article GET IT
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 Academic Article GET IT
Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model. Journal of Thrombosis and Thrombolysis. 2005 Academic Article GET IT
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheterization and Cardiovascular Interventions. 2005 Academic Article GET IT
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: Results of the XaNADU-ACS Trial. Journal of Thrombosis and Haemostasis. 2005 Academic Article GET IT
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: A registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The complication after thrombocytopenia caused by heparin (CATCH) registry steering commitee. Journal of Thrombosis and Thrombolysis. 2005 Academic Article GET IT
Idiopathic sinus of valsalva to right atrial fistula: An unusual origin of right-sided heart failure. Journal of the American Society of Echocardiography. 2004 Academic Article GET IT
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative. JAMA - Journal of the American Medical Association. 2004 Academic Article GET IT
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: A REPLACE-2 substudy. Journal of the American College of Cardiology. 2004 Academic Article GET IT
Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention. Journal of Clinical Pharmacology. 2004 Academic Article GET IT
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA - Journal of the American Medical Association. 2004 Academic Article GET IT
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: An open-label, nonrandomized pilot study. Journal of Thrombosis and Thrombolysis. 2004 Academic Article GET IT
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: Design and rationale of the SYNERGY Library. American Heart Journal. 2004 Academic Article GET IT
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. American Journal of Cardiology. 2004 Academic Article GET IT
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. American Journal of Cardiology. 2004 Academic Article GET IT
Dynamic prognostication in non-ST-elevation acute coronary syndromes: Insights from GUSTO-IIb and PURSUIT. American Heart Journal. 2004 Academic Article GET IT
Platelets, the cardiologist, and coronary artery disease: Moving beyond aggregation. Journal of the American College of Cardiology. 2004 Editorial Article GET IT
Acute myocardial infarction: Clinical characteristics, management and outcome in a university medical centre in a developing Middle Eastern country. Canadian Journal of Cardiology. 2004 Academic Article GET IT
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. Canadian Journal of Cardiology. 2004 Academic Article GET IT
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). American Journal of Cardiology. 2004 Academic Article GET IT
Aspirin dose and six-month outcome after an acute coronary syndrome. Journal of the American College of Cardiology. 2004 Academic Article GET IT
Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: Acute coronary syndromes and elective stenting. American Journal of Cardiovascular Drugs. 2004 Article GET IT
Differential Treatment Benefit of Platelet Glycoprotein IIb/IIIa Inhibition with Percutaneous Coronary Intervention Versus Medical Therapy for Acute Coronary Syndromes: Exploration of Methods. Circulation. 2004 Academic Article GET IT
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: The XaNADU-PCI pilot. Journal of Thrombosis and Haemostasis. 2004 Academic Article GET IT
Patient-specific antiplatelet therapy. Journal of Thrombosis and Thrombolysis. 2004 Review GET IT
Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability. Clinical Pharmacology and Therapeutics. 2004 Academic Article GET IT
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA - Journal of the American Medical Association. 2004 Academic Article GET IT
Therapeutic strategies for cardiogenic shock. Current Treatment Options in Cardiovascular Medicine. 2004 Article GET IT
Platelet-monocyte complex formation: Effect of blocking PSGL-1 alone, and in combination with αiIbβ3 and αmβ2, in coronary stenting. Thrombosis Research. 2003 Academic Article GET IT
Simultaneous Modeling of Abciximab Plasma Concentrations and ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty. Journal of Pharmacology and Experimental Therapeutics. 2003 Academic Article GET IT
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease. American Journal of Cardiology. 2003 Article GET IT
Evolving revascularization approaches for myocardial ischemia. American Journal of Cardiology. 2003 Article GET IT
A Randomized, Double-Blind, Placebo-Controlled Trial of Ad5FGF-4 Gene Therapy and its Effect on Myocardial Perfusion in Patients with Stable Angina. Journal of the American College of Cardiology. 2003 Academic Article GET IT
Arterial thrombosis for the interventional cardiologist: From adhesion molecules and coagulation factors to clinical therapeutics. Catheterization and Cardiovascular Interventions. 2003 Review GET IT
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: Insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003 Review GET IT
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the evaluating enoxaparin clotting times (ELECT) study. Journal of the American College of Cardiology. 2003 Article GET IT
Bivalirudin, thrombin and platelets: Clinical implications and future directions. Journal of Invasive Cardiology. 2003 Article GET IT
Bivalirudin, thrombin and platelets: clinical implications and future directions. Journal of Invasive Cardiology. 2003 Review GET IT
Platelet abnormalities in diabetes mellitus. Coronary Artery Disease. 2003 Article GET IT
Soluble CD40 ligand in acute coronary syndromes [1] (multiple letters). New England Journal of Medicine. 2003 Article GET IT
Combination therapy for acute myocardial infarction: Will it survive?. Journal of the American College of Cardiology. 2003 Article GET IT
Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Canadian Journal of Cardiology. 2003 Academic Article GET IT
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared with Heparin and Planned Glycoprotein IIb/IIIa Blockade during Percutaneous Coronary intervention: REPLACE-2 Randomized Trial. JAMA - Journal of the American Medical Association. 2003 Academic Article GET IT
Soluble CD40 ligand in acute coronary syndromes. New England Journal of Medicine. 2003 Comment
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus. American Heart Journal. 2002 Academic Article GET IT
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study. Journal of the American College of Cardiology. 2002 Academic Article GET IT
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. Journal of the American College of Cardiology. 2002 Academic Article GET IT
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes: Gradient of benefit related to the revascularization strategy. European Heart Journal. 2002 Academic Article GET IT
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. The American Journal of Medicine. 2002 Academic Article GET IT
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). American Heart Journal. 2002 Academic Article GET IT
Antiplatelet therapy and coronary interventions: Childhood friends or permanent partners?. Journal of Interventional Cardiology. 2002 Academic Article GET IT
Glycoprotein IIb/IIIa antagonists in the setting of rescue percutaneous coronary intervention. Journal of Interventional Cardiology. 2002 Review GET IT
First experience with direct factor Xa inhibition in patients with stable coronary disease: A pharmacokinetic and pharmacodynamic evaluation. Circulation. 2002 Academic Article GET IT
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. American Heart Journal. 2002 Academic Article GET IT
Pharmacodynamics of abciximab during angioplasty: Comparison to healthy subjects. Clinical Pharmacology and Therapeutics. 2002 Academic Article GET IT
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation. 2002 Academic Article GET IT
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. JAMA - Journal of the American Medical Association. 2002 Academic Article GET IT
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. American Heart Journal. 2002 Academic Article GET IT
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. European Heart Journal. 2002 Academic Article GET IT
Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial. American Heart Journal. 2002 Academic Article GET IT
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. American Heart Journal. 2002 Academic Article GET IT
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2001 Review GET IT
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (The PRIDE Study). American Journal of Cardiology. 2001 Academic Article GET IT
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction end- points in an international clinical trial: Review of the PURSUIT study. Current Controlled Trials in Cardiovascular Medicine. 2001 Academic Article GET IT
Systematic adjudication of myocardial infarction end-points in an international clinical trial. Current Controlled Trials in Cardiovascular Medicine. 2001 Academic Article GET IT
Issues in cardiac intervention for UA/NSTEMI. European Heart Journal, Supplement. 2001 Conference Paper GET IT
Abciximab readministration: Results of the ReoPro Readministration Registry. Circulation. 2001 Academic Article GET IT
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: Prospective analysis from PURSUIT. Circulation. 2001 Academic Article GET IT
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. Circulation. 2001 Academic Article GET IT
Low-Molecular-Weight Heparins. Journal of Invasive Cardiology. 2001 Academic Article GET IT
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study. The Lancet. 2001 Academic Article GET IT
Dalteparin in combination with abciximab during percutaneous coronary intervention. American Heart Journal. 2001 Academic Article GET IT
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. Circulation. 2000 Academic Article GET IT
Low molecular weight heparins. Expert Opinion on Pharmacotherapy. 2000 Review GET IT
Platelet activation in acute myocardial infarction and the rationale for combination therapy. Current Cardiology Reports. 2000 Academic Article GET IT
Putting heparin into perspective: Its history and the evolution of its use during Percutaneous Coronary Interventions. Journal of Invasive Cardiology. 2000 Academic Article GET IT
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions. American Heart Journal. 2000 Academic Article GET IT
Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials. Annals of Thoracic Surgery. 2000 Academic Article GET IT
Management of patients with acute coronary syndromes in the United States by platelet Glycoprotein IIb/IIIa inhibition: Insights from the Platelet Glycoprotein IIb/IIIa in Unstable Angina. Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Circulation. 2000 Academic Article GET IT
Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG and epistent trials. Journal of the American College of Cardiology. 2000 Academic Article GET IT
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (thrombolysis in myocardial infarction) 14. Circulation. 2000 Academic Article GET IT
Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the IIb/IIIa antagonist abciximab. American Heart Journal. 2000 Academic Article GET IT
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). American Journal of Cardiology. 2000 Academic Article GET IT
Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation. 2000 Academic Article GET IT
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. Circulation. 2000 Academic Article GET IT
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction. Journal of Thrombosis and Thrombolysis. 2000 Academic Article GET IT
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro. Journal of Thrombosis and Thrombolysis. 2000 Academic Article GET IT
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation. 2000 Academic Article GET IT
Redefining medical treatment in the management of unstable angina. The American Journal of Medicine. 2000 Article GET IT
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. Journal of the American College of Cardiology. 2000 Academic Article GET IT
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation. 1999 Academic Article GET IT
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial. The Lancet. 1999 Academic Article GET IT
Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors. American Heart Journal. 1999 Article GET IT
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (Results from the GUSTO-III trial). American Journal of Cardiology. 1999 Academic Article GET IT
Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy [5] (multiple letters). Circulation. 1999 Article GET IT
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. New England Journal of Medicine. 1999 Academic Article GET IT
Platelet glycoprotein IIb/IIIa antagonists: What are the relevant issues concerning their pharmacology and clinical use?. Circulation. 1999 Review GET IT
Antiplatelet therapy for treatment of acute coronary syndromes. Cardiology Clinics. 1999 Article GET IT
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome: The platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (pursuit) trial experience. Circulation. 1999 Academic Article GET IT
Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial. Circulation. 1999 Academic Article GET IT
GP IIb/IIIa antagonists. Clinical experience and potential uses in cardiology. Drugs in R and D. 1999 Review GET IT
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab. One-year outcome in the EPILOG trial. Circulation. 1999 Academic Article GET IT
Much ado about thrombin. American Heart Journal. 1999 Editorial Article GET IT
A risk-benefit assessment of abciximab in angioplasty. Drug Safety. 1999 Academic Article GET IT
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb. American Heart Journal. 1999 Academic Article GET IT
Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty. Journal of the American College of Cardiology. 1999 Academic Article GET IT
Safety issues surrounding use of platelet GP IIb/IIIa antagonists: Reversibility and readministration. European Heart Journal, Supplement. 1999 Conference Paper
Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists. Coronary Artery Disease. 1998 Review GET IT
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. Journal of the American College of Cardiology. 1998 Academic Article GET IT
Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: A prospective, randomized pilot study. Circulation. 1998 Academic Article GET IT
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: Pathophysiologic foundation and clinical findings. American Heart Journal. 1998 Article GET IT
Relation between inhibition of platelet aggregation and clinical outcomes. American Heart Journal. 1998 Article GET IT
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Academic Article GET IT
Glycoprotein IIb-IIIa Antagonists in Percutaneous Coronary Interventions and Acute Coronary Syndromes. Indian Heart Journal. 1998 Review GET IT
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized trial. Circulation. 1998 Academic Article GET IT
Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow. American Heart Journal. 1998 Academic Article GET IT
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. American Journal of Cardiology. 1998 Academic Article GET IT
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Journal of the American College of Cardiology. 1998 Academic Article GET IT
Fistula between left main, left anterior descending, and pulmonary arteries. Circulation. 1998 Academic Article GET IT
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: Evidence for a complex interaction in a multicenter trial. Circulation. 1998 Academic Article GET IT
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. American Heart Journal. 1998 Academic Article GET IT
Benefit of early sustained reperfusion in patients with prior myocardial infarction (The GUSTO-I Trial). American Journal of Cardiology. 1998 Academic Article GET IT
Myonecrosis after revascularization procedures. Journal of the American College of Cardiology. 1998 Article GET IT
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. Journal of the American College of Cardiology. 1998 Academic Article GET IT
Does the early hazard phenomenon exist?: Do the GUSTO findings prove or disprove? [1] (multiple letters). Circulation. 1997 Article GET IT
Physicians' use of heparin following thrombolytic therapy: An international perspective. Journal of Thrombosis and Thrombolysis. 1997 Academic Article GET IT
Roundtable panel discussion: The role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes. American Journal of Cardiology. 1997 Article GET IT
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment. Circulation. 1997 Academic Article GET IT
Primary and secondary safety endpoints from IMPACT II. American Journal of Cardiology. 1997 Article GET IT
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β3 blockade with percutaneous coronary intervention. JAMA - Journal of the American Medical Association. 1997 Academic Article GET IT
Use of bare-mounted Palmaz-Schatz stents employing the stent saddle technique on the delivery balloon: A single center experience. Catheterization and Cardiovascular Diagnosis. 1997 Academic Article GET IT
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. Journal of the American College of Cardiology. 1997 Academic Article GET IT
Hypertrophic obstructive cardiomyopathy: Alternative therapeutic options. Clinical Cardiology. 1997 Editorial Article GET IT
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose- ranging trial. Circulation. 1997 Academic Article GET IT
Hemorrhagic Events during Therapy with Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis in Myocardial Ischemia, Phase IIIB Trial). American Journal of Cardiology. 1997 Academic Article GET IT
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III registry and TIMI IIIB). American Journal of Cardiology. 1997 Academic Article GET IT
Effects of integrelin on platelet function in flow models of arterial thrombosis. Journal of Cardiovascular Pharmacology. 1997 Academic Article GET IT
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment Abciximab (c7E3 Fab) during percutaneous coronary revascularization. American Journal of Cardiology. 1997 Academic Article GET IT
Visualization of ventricular fibroelastoma with a video-assisted thoracoscope. Annals of Thoracic Surgery. 1997 Academic Article GET IT
Clinical benefit within patient subgroups receiving c7E3 Fab (abciximab) during percutaneous coronary revascularization: Subgroup analysis from the EPIC trial. Journal of Invasive Cardiology. 1996 Academic Article GET IT
Inhibition of coronary restenosis by antithrombin III in atherosclerotic swine. Coronary Artery Disease. 1996 Academic Article GET IT
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. American Journal of Cardiology. 1996 Academic Article GET IT
Clinical trials of conjunctive anticoagulant strategies in thrombolysis. Coronary Artery Disease. 1996 Review GET IT
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. New England Journal of Medicine. 1996 Academic Article GET IT
Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial. Circulation. 1996 Academic Article GET IT
Platelet glycoprotein IIIa Pl(A) polymorphism and myocardial infarction [5]. New England Journal of Medicine. 1996 Article GET IT
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab: Administration for complex coronary intervention. Circulation. 1996 Academic Article GET IT
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA - Journal of the American Medical Association. 1996 Academic Article GET IT
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. Journal of the American College of Cardiology. 1996 Academic Article GET IT
Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). American Journal of Cardiology. 1996 Academic Article GET IT
Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. Journal of the American Society of Echocardiography. 1996 Academic Article GET IT
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention. American Journal of Cardiology. 1995 Academic Article GET IT
Description of patients undergoing high risk angioplasty. Analyses of various databases. European Heart Journal. 1995 Review GET IT
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor. European Heart Journal. 1995 Review GET IT
Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. Journal of Investigative Medicine. 1995 Academic Article GET IT
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. Circulation. 1995 Academic Article GET IT
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology. 1995 Academic Article GET IT
Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation. 1995 Academic Article GET IT
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation. 1995 Academic Article GET IT
Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience. Journal of the American College of Cardiology. 1995 Academic Article GET IT
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. Journal of the American College of Cardiology. 1995 Academic Article GET IT
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors. Journal of the American College of Cardiology. 1995 Academic Article GET IT
Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995 Academic Article GET IT
Platelets and platelet inhibitors in acute myocardial infarction. Cardiology Clinics. 1995 Review GET IT
Mortality within 24 hours of thrombolysis for myocardial infarction: The importance of early reperfusion. Circulation. 1994 Academic Article GET IT
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. American Journal of Cardiology. 1994 Academic Article GET IT
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation. 1994 Academic Article GET IT
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy: Results from the TIMI II study. Circulation. 1994 Academic Article GET IT
Recombinant hirudin for unstable angina pectoris a multicenter, randomized angiographic trial. Circulation. 1994 Academic Article GET IT
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'. Circulation. 1994 Review GET IT
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Journal of the American College of Cardiology. 1994 Academic Article GET IT
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set' [6]. Circulation. 1994 Article GET IT
Heterotopic heart transplantation: catheterization, endomyocardial biopsy, and coronary angiography of the donor heart. Catheterization and Cardiovascular Diagnosis. 1994 Academic Article GET IT
Is intravascular ultrasound better than quantitative coronary arteriography to assess cardiac allograft arteriopathy?. Catheterization and Cardiovascular Diagnosis. 1994 Academic Article GET IT
Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction. American Heart Journal. 1994 Academic Article GET IT
What are the implications of cardiac infection with cytomegalovirus before heart transplantation?. Journal of Heart and Lung Transplantation. 1994 Academic Article GET IT
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. American Journal of Cardiology. 1993 Academic Article GET IT
Transesophageal echocardiographic demonstration of right coronary artery-to-coronary sinus fistula in a heart transplant recipient. Journal of the American Society of Echocardiography. 1993 Academic Article GET IT
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New England Journal of Medicine. 1993 Academic Article GET IT
Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplantation Proceedings. 1993 Academic Article GET IT
Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation. Journal of Heart and Lung Transplantation. 1993 Academic Article GET IT
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy. Results of the thrombolysis and angioplasty in mycardial infaraction (TAMI) 8 pilot study. Journal of the American College of Cardiology. 1993 Academic Article GET IT
Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial. Journal of the American College of Cardiology. 1993 Academic Article GET IT
High-speed coronary rotational angioplasty with the rotablator. Proceedings of SPIE - The International Society for Optical Engineering. 1992 Conference Paper
Rotational ablation of coronary artery lesions using single, large burrs. Catheterization and Cardiovascular Diagnosis. 1992 Academic Article GET IT
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Journal of the American College of Cardiology. 1992 Academic Article GET IT
Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/American Heart Association grading criteria. American Journal of Cardiology. 1992 Academic Article GET IT
Aspirin, Heparin, and Other Ancillary Therapies Following Thrombolysis. Journal of Interventional Cardiology. 1992 Academic Article GET IT
Coronary angiography after heart transplantation: Should perioperative study be the 'gold standard'?. Journal of Heart and Lung Transplantation. 1992 Academic Article GET IT
Effectiveness of videotaped dietary instruction for patients hospitalized with cardiovascular disease. Journal of the American Dietetic Association. 1992 Academic Article GET IT
Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance. Journal of the American College of Cardiology. 1992 Academic Article GET IT
Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency. Journal of the American College of Cardiology. 1992 Academic Article GET IT
Percutaneous transluminal coronary angioplasty: Its role in cardiogenic shock. Primary Cardiology. 1992 Report
The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation. Journal of Heart and Lung Transplantation. 1992 Academic Article GET IT
Goals of thrombolytic therapy. American Journal of Cardiology. 1991 Academic Article GET IT
Diagnosis of ischemic heart disease with adenosine echocardiography. Journal of the American College of Cardiology. 1991 Academic Article GET IT
Detection of transplant arteriopathy: Does exercise thallium scintigraphy improve noninvasive diagnostic capabilities?. Transplantation Proceedings. 1991 Academic Article GET IT
Effects of intracoronary acetylcholine infusion early versus late after heart transplant. Transplantation Proceedings. 1991 Academic Article GET IT
Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy. Journal of Heart and Lung Transplantation. 1991 Academic Article GET IT
Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: Primacy of baseline ejection fraction. Journal of the American College of Cardiology. 1991 Academic Article GET IT
Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation. 1991 Academic Article GET IT
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. New England Journal of Medicine. 1990 Academic Article GET IT
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris: Results of a placebo-controlled, randomized trial. Circulation. 1990 Academic Article GET IT
Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. American Heart Journal. 1990 Academic Article GET IT
Factors influencing the outcome of balloon aortic valvuloplasty in the elderly. American Heart Journal. 1990 Academic Article GET IT
Lack of diurnal variation in the onset of non-Q wave infarction. Circulation. 1990 Academic Article GET IT
Percutaneous transluminal coronary angioplasty in octogenarians. Annals of Internal Medicine. 1990 Academic Article GET IT
Percutaneous transluminal coronary angioplasty: Is what we see what we get?. Journal of the American College of Cardiology. 1990 Article GET IT
Early intravenous thrombolytic therapy for acute myocardial infarction in patients with prior coronary artery bypass grafts. American Journal of Cardiology. 1989 Academic Article GET IT
Helicopter transport of patients with acute myocardial infarction. Texas Medicine. 1988 Academic Article GET IT
Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location. American Journal of Cardiology. 1988 Academic Article GET IT
Arteriographic demonstration of coronary artery spasm during thrombolysis. Texas Heart Institute Journal. 1988 Academic Article GET IT
Percutaneous transluminal coronary angioplasty in the treatment of patients with unstable angina and acute myocardial infarction. Problems in Critical Care. 1988 Academic Article
Thrombolytic therapy in acute myocardial infarction. Problems in Critical Care. 1988 Academic Article
Thrombolytic treatment for acute myocardial infarction. Texas Medicine. 1988 Review GET IT
Prinzmetal's angina during 5-fluorouracil chemotherapy. The American Journal of Medicine. 1987 Academic Article GET IT
Right-to-left intracardiac shunt and constrictive pericarditis following coronary artery bypass surgery. American Heart Journal. 1987 Academic Article GET IT
Prognostic significance of initial blood glucose levels in acute myocardial infarction. Harefuah. 1982 Academic Article GET IT
Anticoagulant therapy in acute myocardial infarction: Demonstration of a selection bias in a retrospective study. Thrombosis Research. 1980 Academic Article GET IT
M.D., Columbia University College of Physicians and Surgeons 1981
A.B., Princeton University 1977